Academia Sinica develops new antibody able to kill cancer cells

A research team at Taiwan's top academic research institution has developed a new antibody tool that has shown promising results in killing malignant tumor cells in mice and could eventually be turned into a therapeutic drug.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)